Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trega Biosciences (TRGA), formerly HPIP -- Ignore unavailable to you. Want to Upgrade?

To: bob s who wrote (64)	5/29/1998 6:28:00 PM
From: E.J. Neitz Jr	Respond to of 152

Bob, Over the years I have learned that most of the smaller biotechs make great trades. There simply is not enough institutional ownership in them. I buy very low--and yes--many times average down---then sell after one of these run-ups. I like Trega because they provide a service to other pharm and biotech companies--this generates revenue--and in my opinion--a future buyout by a large pharm co. With my luck, trading often--then big byout will happen when I am out of the stock--has happened before . My feeling is that institutions were prunning their portfolios the past few days of low priced stocks. At this price TRGA is a buy.